Conjunctival Findings in Patients With Coronavirus Disease 2019 | JAMA Ophthalmology | JAMA Network
[Skip to Navigation]
Views 1,620
Citations 0
Comment & Response
December 23, 2020

Conjunctival Findings in Patients With Coronavirus Disease 2019

Author Affiliations
  • 1Department of Ophthalmology, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, Hangzhou, Zhejiang Province, China
  • 2Eye Center, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China
JAMA Ophthalmol. 2021;139(2):253-254. doi:10.1001/jamaophthalmol.2020.5813

To the Editor We read with interest the article of Wu et al1 on the characteristics of ocular findings in patients with novel coronavirus disease (COVID-19). Wu et al1 reported that ocular manifestations consistent with conjunctivitis were found in 12 of 38 patients (31.6%) with COVID-19 and concluded that ocular abnormalities frequently occurred in patients with more severe COVID-19 and acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could be transmitted via the eyes. However, we consider that the conjunctivitis Wu et al1 described in their article may not be caused by SARS-CoV-2 infection, ophthalmic involvement may not be associated with the severity of COVID-19, and the eye is not likely to play as a transmission route of SARS-CoV-2 infection, based on previous investigations and the findings of Wu et al.1

As we know, viral conjunctivitis is typically characterized by diffuse conjunctival congestion and watery secretion, followed by mucinous or mucopurulent discharge.2 Conjunctival congestion accompanied by COVID-19 may be associated with SARS-CoV-2 infection or nonpathogenic causes, such as dry eye and chronic noninfective conjunctivitis, because of long-term short-distance reading or entertainment, which is quite common during quarantine.3 In fact, conjunctival congestion and increased secretion only existed in 2 of the 12 patients with conjunctivitis reported by Wu et al.1 Moreover, Wu et al1 did not describe whether the patients recruited in their study had a medical history of ophthalmic diseases and how long the patients spent on short-distance reading or entertainment. Hence, their conclusion that the ophthalmic involvement is associated with the severity of COVID-19 may not be appropriate.

Although conjunctiva is directly exposed to infectious droplets and fomites contaminating the ocular surface via splashing or hand-to-eye touching, viral conjunctivitis rarely occurs in patients with COVID-19.2-4 Viral conjunctivitis has been reported in 5 cases and SARS-CoV-2 RNA detected in 5 patients with COVID-19.2 These reports, however, do not determine the prevalence among individuals with COVID-19. The rarity of viral conjunctivitis in patients with COVID-19 may be interpreted by the less abundant expression of angiotensin-converting enzyme 2, the entry receptor of SARS-CoV-2, on conjunctival epithelial cells and poor binding capability of angiotensin-converting enzyme 2 protein on conjunctival epithelial cells to SARS-CoV-2 spike protein, as well as the protective effect of the antimicrobial agents in tears (eg, lactoferrin and secretory IgA) and tear rinsing, which continuously eliminate the viruses on ocular surface into nasal cavity through nasolacrimal duct.2 Hence, the conjunctiva is likely not a preferred portal of entry for SARS-CoV-2 to cause respiratory tract infection; SARS-CoV-2 exposed to the ocular surface may be continuously transported to nasal and nasopharyngeal mucosa by constant tear rinsing through the nasolacrimal duct and then cause COVID-19.2,4,5

Back to top
Article Information

Corresponding Author: Chuan-bin Sun, MD, PhD, Eye Center, Second Affiliated Hospital of Zhejiang University School of Medicine, Jiefang Rd 88, Hangzhou 310009, Zhejiang Province, China (

Published Online: December 23, 2020. doi:10.1001/jamaophthalmol.2020.5813

Conflict of Interest Disclosures: None reported.

Wu  P, Duan  F, Luo  C,  et al.  Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei province, China.   JAMA Ophthalmol. 2020;138(5):575-578. doi:10.1001/jamaophthalmol.2020.1291PubMedGoogle ScholarCrossref
Sun  C, Wang  Y, Liu  G, Liu  Z.  Role of the eye in transmitting human coronavirus: what we know and what we do not know.   Preprints. 2020. doi:10.20944/preprints202003.0271.v2Google Scholar
Chen  L, Deng  C, Chen  X,  et al  Ocular manifestations and clinical characteristics of 534 cases of COVID-19 in China: a cross-sectional study.   medRxiv. 2020. doi:10.1101/2020.03.12.20034678Google Scholar
Peng  Y, Zhou  YH.  Is novel coronavirus disease (COVID-19) transmitted through conjunctiva?   J Med Virol. 2020. doi:10.1002/jmv.25753PubMedGoogle Scholar
Deng  W, Bao  L, Gao  H,  et al  Rhesus macaques can be effectively infected with SARS-CoV-2 via ocular conjunctival route.   bioRxiv. 2020. doi:10.1101/2020.03.13.990036Google Scholar
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words